Can we predict dangerous side effects when combining radiation and immunotherapy?

NCT ID NCT04115267

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This study is a large registry that tracks cancer patients who receive both radiotherapy and molecular therapies, such as immunotherapy. The goal is to better understand how these two treatments interact and to identify how often severe side effects occur. By collecting data from thousands of patients, researchers hope to improve safety and guide future treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Radiotherapy combined with molecular therapies (immunotherapy or signaling pathway modulators)
What this could lead to
If successful, this could lead to better prediction and management of severe side effects in cancer patients receiving combined radiotherapy and immunotherapy, improving treatment safety.
What could go wrong
This is an observational registry, not a treatment trial, so it won't directly test a new therapy. Results depend on real-world data and may not capture all variables affecting side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Hospitalier de l'Université de Montréal

    RECRUITING

    Montreal, Quebec, H2X 0A9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.